Louise A. Fearfield

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Severely dysplastic naevi: a call for national guidance.

Severely dysplastic naevi: a call for national guidance.

Journal: Clinical and experimental dermatology

Published: April 16, 2025

Astellas article: UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinoma.

Astellas article: UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinoma.

Journal: The oncologist

Published: April 07, 2025

Comparing the number-needed-to-biopsy ratio for melanoma diagnosis by artificial intelligence as a medical device, teledermatology and face-to-face models of care.

Comparing the number-needed-to-biopsy ratio for melanoma diagnosis by artificial intelligence as a medical device, teledermatology and face-to-face models of care.

Journal: Clinical and experimental dermatology

Published: March 04, 2025

Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.

Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitors.

Journal: The British journal of dermatology

Published: February 04, 2024

Resilience in skin disease.

Resilience in skin disease.

Journal: The British journal of dermatology

Published: August 25, 2023

How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach.

How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach.

Journal: The British journal of dermatology

Published: July 21, 2023

Checkpoint inhibitor therapy and psoriasis: a case series.

Checkpoint inhibitor therapy and psoriasis: a case series.

Journal: Clinical and experimental dermatology

Published: February 10, 2023

Athena Speciality Certificate Examination case for formulation and systemic therapy.

Athena Speciality Certificate Examination case for formulation and systemic therapy.

Journal: Clinical and experimental dermatology

Published: June 20, 2022

Mentorship in dermatology: a necessity in difficult times.

Mentorship in dermatology: a necessity in difficult times.

Journal: Clinical and experimental dermatology

Published: December 07, 2021

Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study.

Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study.

Journal: The British journal of dermatology

Published: September 30, 2021

Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit?

Severe cutaneous adverse reaction following COVID-19 vaccination and immunotherapy: a second hit?

Journal: Clinical and experimental dermatology

Published: July 08, 2021

Severe progressive scarring pembrolizumab-induced lichen planopilaris in a patient with metastatic melanoma.

Severe progressive scarring pembrolizumab-induced lichen planopilaris in a patient with metastatic melanoma.

Journal: The Australasian journal of dermatology

Published: May 02, 2021

Showing 1-12 of 37

Last Updated: 09/26/2026